Product Images Cymbalta

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Cymbalta NDC 0002-3270 by Eli Lilly And Company, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structural Formula - cymbalta 01

Structural Formula - cymbalta 01

Figure 3 - cymbalta 02

Figure 3 - cymbalta 02

Figure 4 - cymbalta 03

Figure 4 - cymbalta 03

Figure 5 - cymbalta 13

Figure 5 - cymbalta 13

Figure 6 - cymbalta 14

Figure 6 - cymbalta 14

Figure 7 - cymbalta 15

Figure 7 - cymbalta 15

This is a chart showing the percentage of patients who improved while taking a placebo versus CYM60/120 mg once daily for pain relief. The percentage of improvement ranges from 0% to 100%. The X-axis shows the percentage improvement in pain from baseline (BOCF).*

Figure 8 - cymbalta 16

Figure 8 - cymbalta 16

The text describes the percentage of patients improved using a placebo versus CYMB0 mg once daily. It includes a chart showing the percentage improvement in pain from baseline.*

Figure 9 - cymbalta 17

Figure 9 - cymbalta 17

Figure 1 - cymbalta 18

Figure 1 - cymbalta 18

The text appears to depict a graph showing the proportion of patients with relapse after treatment with either a placebo or a medication called Cymbalta. The x-axis represents the time (in days) from randomization to relapse, while the y-axis represents the proportion of patients. The graph shows that Cymbalta may have a lower proportion of patients experiencing relapse compared to the placebo, but without further context, it is difficult to assess the significance of this information.*

Figure 2 - cymbalta 19

Figure 2 - cymbalta 19

cymbalta 20

cymbalta 20

The text provides a graph showing the percentage of patients improved along with the percentage improvement in pain from baseline for a medication named 'Gymbalta' in comparison to a placebo. Not available information about the study, patients, or the medical condition treated.*

cymbalta 20mg contain 049 01

cymbalta 20mg contain 049 01

cymbalta 30mg contain 063 02

cymbalta 30mg contain 063 02

cymbalta 60mg contain 052 01

cymbalta 60mg contain 052 01

This text provides information on a medicine with the NDC code 0002-3270-30, which is available in the form of 30 capsules. The medication is called duloxetine capsules and each capsule contains 60 mg of the active ingredient. The text also includes the Rx only label, suggesting that this is a prescription medication. There is also some unclear text at the end, which reads "Soeazsc 15506 ot".*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.